Head to Head Contrast: biote (NASDAQ:BTMD) vs. Ramsay Health Care (OTCMKTS:RMSYF)

Ramsay Health Care (OTCMKTS:RMSYF) and biote (NASDAQ:BTMD) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk.

Analyst Ratings

This is a summary of current ratings for Ramsay Health Care and biote, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ramsay Health Care	0	0	1	0	3.00
biote	1	1	1	1	2.50

Ramsay Health Care presently has a consensus price target of $54.10, indicating a potential upside of 47.75%. biote has a consensus price target of $2.50, indicating a potential upside of 59.24%. Given biote’s higher possible upside, analysts clearly believe biote is more favorable than Ramsay Health Care.

Institutional & Insider Ownership

13.2% of Ramsay Health Care shares are held by institutional investors. Comparatively, 21.7% of biote shares are held by institutional investors. 32.4% of biote shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Ramsay Health Care and biote’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Ramsay Health Care	N/A	N/A	N/A
biote	3.19%	-22.33%	12.10%

Earnings and Valuation

This table compares Ramsay Health Care and biote”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ramsay Health Care	N/A	N/A	N/A	$1.43	25.60
biote	$192.22 million	0.29	$27.05 million	$0.11	14.27

biote has higher revenue and earnings than Ramsay Health Care. biote is trading at a lower price-to-earnings ratio than Ramsay Health Care, indicating that it is currently the more affordable of the two stocks.

Summary

biote beats Ramsay Health Care on 7 of the 11 factors compared between the two stocks.

About Ramsay Health Care

Ramsay Health Care Limited owns and operates hospitals. The company offers health care services to public and private patients. It operates facilities in approximately 530 locations in the Asia Pacific, the United Kingdom, France, and Nordics. Ramsay Health Care Limited was founded in 1964 and is based in Sydney, Australia.

About biote

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.